A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/02/2006	EP1715871A1 Kinase inhibitor phosphonate conjugates
11/02/2006	EP1715870A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
11/02/2006	EP1715869A1 Method of stimulating hair growth
11/02/2006	EP1715868A1 Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1715866A2 Protease inhibitors for treatment of wrinkles
11/02/2006	EP1715865A2 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
11/02/2006	EP1715864A1 Use of siramesine in the treatment of cancer
11/02/2006	EP1715863A2 Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors
11/02/2006	EP1715862A1 Kinase inhibitors
11/02/2006	EP1715861A2 Compositions comprising prodrugs of proton pump inhibitors
11/02/2006	EP1715860A1 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
11/02/2006	EP1715859A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
11/02/2006	EP1715858A2 Topical treatment of otitis externa with antifungals or antibacterials
11/02/2006	EP1715857A1 Amidine derivatives for treating amyloidosis
11/02/2006	EP1715856A1 Atomoxetine formulations
11/02/2006	EP1715855A2 Anti-viral therapeutics
11/02/2006	EP1715854A2 Prodrugs for the intravenous administration of proton pump inhibitors
11/02/2006	EP1715853A1 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
11/02/2006	EP1715852A2 Non-disintegrating oral solid composition of high dose of water soluble drugs
11/02/2006	EP1715850A2 Pharmaceutical composition for oral application and method for preparing thereof
11/02/2006	EP1715849A1 Stable pharmaceutical solution formulation for pressurized metered dose inhalers
11/02/2006	EP1715848A1 Microemulsion formulations comprising particular substance p antagonists
11/02/2006	EP1715847A1 Self-microemulsifying drug delivery systems of a hiv protease inhibitor6
11/02/2006	EP1715846A2 Dissolvable film and method of manufacture
11/02/2006	EP1715843A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadph-inhibitor for the treatment of central nervous system-related conditions
11/02/2006	EP1715761A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
11/02/2006	EP1715742A1 Compositions and methods for sleep regulation
11/02/2006	EP1660068A4 Composition for treatment of tinea pedis and method of use
11/02/2006	EP1633352B1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain
11/02/2006	EP1631575B1 NEW 3-DECLADINOSYL 9a-N -CARBAMOYL AND 9a-N -THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A-HOMOERYTHROMYCIN A
11/02/2006	EP1589955B1 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
11/02/2006	EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof
11/02/2006	EP1565186B1 N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
11/02/2006	EP1556037B1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity
11/02/2006	EP1554237A4 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
11/02/2006	EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006	EP1537065B1 Analogues of vitamin d
11/02/2006	EP1517682B1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
11/02/2006	EP1515967B1 2-heteroaryl carboxamides
11/02/2006	EP1509215B1 Treatment or prevention of urogenital atrophy and its symptoms in women
11/02/2006	EP1501565B1 Compounds and method for coating surfaces in a haemocompatible manner
11/02/2006	EP1485040B1 Method of administering an injectable antibiotic to the ear of an animal
11/02/2006	EP1480663B1 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
11/02/2006	EP1474172B1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/02/2006	EP1467761B1 Treatment of neovascular ophthalmic disease
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1395568B1 4-aminopyrimidine derivatives
11/02/2006	EP1387689B1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/02/2006	EP1377278B1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
11/02/2006	EP1349537B1 Skin care product containing retinoids and phytoestrogens in a dual compartment package
11/02/2006	EP1343773B1 Thiazole derivatives for traeing ppar related disorders
11/02/2006	EP1339685B1 Biphenylcarboxamides useful as lipid lowering agents
11/02/2006	EP1322351B1 Coated medical devices
11/02/2006	EP1315700B1 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1284984B1 Uridine derivatives as antibiotics
11/02/2006	EP1278525B1 Pyrophosphates for enhancing cellular function through protection of muscarinic receptors
11/02/2006	EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl\|cyclohexanecarboxylate
11/02/2006	EP1244446B1 Thrombopoietin mimetics
11/02/2006	EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006	EP1219596B1 Salicylamide derivatives
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1194144B1 Antibacterial compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006	EP1127045B1 Triphenylbutene derivatives for the treatment of neurological disorders
11/02/2006	EP1102589B1 Topical compositions comprising an opioid analgesic and an nmda antagonist
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/02/2006	EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006	EP1009417B1 Dietary supplements containing natural ingredients
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0999209B1 2-sulfamoylbenzoic acid derivatives
11/02/2006	EP0973534B1 Plant extracts having appetite suppressant activity
11/02/2006	EP0898707B1 Oxidative metabolism in smooth muscle cells: methods relating thereto
11/02/2006	EP0873361B1 Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	EP0823908B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	EP0735883B1 Composition for contraception comprising an estrogen and a gestagen
11/02/2006	DE102005020976A1 Use of thiamine to treat and/or prevent diseases associated with DNA lesion in single and/or double strands e.g. cancer, neurodegenerative disease, inflammatory disease and arteriosclerosis
11/02/2006	DE102005020331A1 New 5-substituted quinoline and isoquinoline derivatives are glucocorticoid receptor binders useful for treating inflammatory diseases e.g. alveolitis, Sjogren's syndrome, atopic dermatitis, acute lymphatic leukemia, rhinitis and emesis
11/02/2006	DE102005020002A1 New hexyloxycarbonylamino-imino-methyl-phenylamino-methyl-benzimidazo le-pyridine-propionic acid-ethyl ester salts such as hydrochloride useful for the prophylaxis of vein thrombosis and stroke
11/02/2006	DE102005019670A1 Preparation of 5-(4-(4-(5-cyano-3-indolyl)-butyl)-1-piperazinyl)-benz ofuran-2-carboxamide, comprises reacting a heterocyclic compound with a carbonitrile compound; and/or converting the obtained benzofuran compound to its salt
11/02/2006	DE102005019201A1 Neue Verbindungen zur Behandlung von entzündlichen Erkrankungen Novel compounds for the treatment of inflammatory diseases
11/02/2006	DE102005018025A1 New heterocyclic compounds which are cytokine interleukin-8 inhibitors useful for treating e.g., chronic obstructive lung disease, bronchitis, rheumatoid arthritis, psoriasis, gastrointestinal disease and Crohn's disease
11/02/2006	CA2814247A1 Polymorphic and amorphous salt forms of squalamine dilactate
11/02/2006	CA2650556A1 Insulins combinations
11/02/2006	CA2611735A1 Therapeutic bifunctional compounds
11/02/2006	CA2609927A1 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	CA2609788A1 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
11/02/2006	CA2609650A1 Doped semiconductor nanocrystals and methods of making same
11/02/2006	CA2609633A1 Nicotinamide riboside compositions

1 ... 4027 4028 4029 4030 4031 4032 4033 4034 4035 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 ... 7860